Skip to main content
ARYA Atherosclerosis logoLink to ARYA Atherosclerosis
. 2014 May;10(3):169–174.

The association of genetic variations with sensitivity of blood pressure to dietary salt: A narrative literature review

Saeid Doaei 1, Maryam Gholamalizadeh 2,
PMCID: PMC4144382  PMID: 25161689

Abstract

Salt sensitivity of blood pressure (BP) is an independent risk factor for cardiovascular morbidity. Up to 50% of patients with essential hypertension are salt-sensitive, as manifested by a rise in BP with salt intake. Several genetic variations have been identified as being associated with salt sensitivity. The present study aimed to review the evidence on the effect of gene polymorphisms on the salt sensitivity of BP. We searched in PubMed website from 1990 to 2011, with the use of following keywords: “hypertension, dietary salt, polymorphisms, and blood pressure”. The effect of sodium intake on BP differed by genotype at the genes of the renin-angiotensin system, aldosterone synthase, cytochrome p450 3A, epithelial sodium channel genes, genes of sympathetic nervous system, β-3 subunit of G-protein, alpha-adducin, endothelial nitric oxide synthase, Kallikrein-Kinin system. These approaches suggest that these polymorphisms may be potentially useful genetic markers of BP response to dietary salt. There is evidence that genetic predisposition modulates the BP response to diet. Therefore, diet and nutrition can mitigate or enhance the effects of genetic predisposition. Increasing our knowledge of this relationship can lead to individualized treatment and increased understanding of hypertension.

Keywords: Hypertension, Genetics, Diet Therapy

Introduction

Hypertension is a major worldwide risk factor for cardiovascular diseases (CVDs) such as heart attack, congestion, heart failure, stroke, and peripheral vascular disease.1 The prevalence of hypertension has dramatically increased in recent years.2 Essential hypertension is a complex disease that characterized by chronically elevation in blood pressure (BP) with no specific underlying medical or biological cause.3 As that shown in the previous studies in the field of similar problems such as hyperlipidemia and other CVDs,4 hypertension is a complex trait resulting from interaction of multiple genetic factors and lifestyle exposures including: dietary salt intake, alcohol consumption, and body weight.5 The heritability of hypertension is often reported in the range of 30-60%.6

Requirements and tolerable upper limits of nutrients could be different in different people.7 Several studies of nutritional genomics have shown that some of the gene variations could influence the level of nutrients requirements.8 On the other hand, intake of some nutrients could alter the gene expression and protein synthesis.9

High dietary sodium intake is the most prevalent risk factor in modern societies. Although many studies found that high dietary salt intake is associated with hypertension, but BP responses to high and low salt intake may be influenced by various genetic factors10 and some studies have suggested that dietary sodium restriction may not be beneficial to everyone. Salt restriction has been reported to decrease cognitive function in salt sensitive and salt resistant population;11 thus, there is a need to recognize the genetics determinants of salt sensitivity that increase our understanding of the mechanism underlying hypertension and finally distinguish salt sensitive from salt resistant subjects.

Salt sensitivity of BP is defined by the observed changes of arterial pressure as daily salt intake is changed.12 Most studies searching for genetics causes of essential hypertension have been observed association between candidate genes with salt sensitive hypertension. These genes including: renin-angiotensin converting enzyme (ACE) gene, angiotensinogen (AGT) gene, angiotensin II type 1 receptor, epithelial sodium channel (ENaC) genes, 11-beta hydroxy steroid dehydrogenase (11-BHSD) genes, sympathetic alpha receptor gene, beta receptor gene, endothelial nitric oxide synthase gene, adducin gene, and others.13

This narrative literature review outlines some of genes associated with salt sensitive hypertension; emphases on genetic variations related to salt sensitivity in individuals and highlight the recent finding on the genetic basis of salt sensitive hypertension.

Genes of Renin-Angiotensin System (RAS)

The renin-angiotensin system (RAS) is the most important regulation of homeostatic system that controls body fluid volume, electrolyte balance, and BP.14

Components of RAS were studied as candidate genes for salt sensitive hypertension. The most studies have examined several loci within this system: the ACE gene, the AGT gene, and the angiotensin type 1 receptor gene.

ACE Gene

Many studies have examined the association between ACE and salt sensitivity.15-17Meneton et al. found that the prevalence of salt sensitivity hypertension in II phenotype and ID phenotype is significantly higher than DD phenotype.15 Zhang et al. found that ACE I/D had been significant association with salt sensitivity hypertension.17

However, reports of the association between ACE genotype and salt sensitivity hypertension were inconsistent. Strazzullo et al. in a meta-analysis of 145 case-control studies observed that DD homozygote and ID heterozygote had increased CVD, but not for hypertension in contrast with II homozygote.18

AGT Gene

Norat et al. found that molecular variants in the AGT gene including M235T, T174M, and mutation in the promoter region that involve in the insertion of adenine instead of guanine (G-6A) had been a positive association with salt sensitivity hypertension19 that was in line with results of two previous studies.20,21 Schorr et al. found that the presence of the AA (or TT) genotype in the promoter region is associated with salt-sensitive BP.21 Also, Hunt et al. found an association between AGT-GG linkages with AGT M235T with a decrease in BP after a decrease in sodium intake.22 Beeks et al. concluded that patients who are homozygous for M allele had lower BP after mild salt restriction compare with TT and MT genotype.23

Svetkey et al. found that BP response to the dietary approaches to stop hypertension (DASH) diet is higher in the genotype of G-6A AGT SNP than GG genotype.24

Angiotensin Type 1 Receptor

Anginotensin II regulates vascular contracting, BP and sodium reabsorbing by kidney through binding with angiotensin II receptor.25 Two subtype of gene variations of angiotensin II type 1 receptor, 1A (AT1AR) and 1B (AT1BR), may effect on BP.26

Moreover, Gu et al. found an association between rs4524238 alleles G/A and A/A with salt sensitivity hypertension.27

Aldestron Synthase

Aldestron secretes by the adrenal gland and has been important in the regulation of water electrolyte balance.28 This hormone synthesize by the aldosterone synthase enzyme, which is encoded by the CYP11B2 gene.29 Many studies reported that CYP11B2 polymorphisms, especially −344C/T are associated with salt sensitivity hypertension.30-32 However, in two studies CYP11B2 T344C polymorphism was not associated with hypertension.18,23

11ΒHSD2 Gene

Mineralocorticoid activity may be increased with decreased activity of 11BHSD2, which inactivates 11-hydroxy steroids in the kidney, thereby protecting the nonselective mineralocorticoid receptor from occupation by glucocorticoids.33 Smolenicka et al. found that Mutations in the 11ΒHSD2 gene may lead to a rare form of salt sensitive hypertension.34 Alikhani-Koupaei et al. identified polymorphism G534A in exon 3 of this gene could increase susceptibility to salt sensitive hypertension.35

Cytochrome p450 3A (Cyp3A)

Cytochrome p450 3A (Cyp3A) is a subfamily of cytochrome P (CYP) 450. This group of cytochromes are involved in the metabolism of drugs (e.g., anti-hypertensive drugs) and endogenous substrate such as steroids. These metabolites effect on renal sodium transport.36 Components of Cyp3A subfamily are located on chromosome 7q22. These genes include Cyp3A4, Cyp3A5, Cyp3A7, and Cyp3A43 (cyt3). Cyp3A5 is of particular interest because it is expressed in the kidney; Cyp3A5*1 expresses the wild-type protein while the Cyp3A5*3 allele (A6986G, rs776746) reduces Cyp3A5 protein expression. In a Japanese population, Zhang et al. found that BP was associated with the level of salt intake in Cyp3A5*3/*3, but not CYP3A5*1/*1.37

ENaC Genes

ENac has major roles in Na+ reabsorption in the distal tubule, regulation of extracellular fluid volume and BP.18 Lifton et al. found that T594M mutation of the β-subunit in black people is associated with a greater chance of hypertension compared with individuals without this mutation.38

On the other hand, neural precursor cell expressed developmentally downregulated 4-like (NEDD4L) is an ubiquitin ligase, express in the distal nephron and regulates the expression of the epithelial Na+ channel.39 Some studies reported association between variation in NEDD4Land salt sensitive hypertension.39,40 Dahlberg et al. found that a common polymorphism located in intron 2 (rs4149601, A/G) of the NEDD4L gene was found to be associated with salt sensitive hypertension.39

Manunta et al. found a combination of two common single nucleotide polymorphisms (rs4149601 and rs2288774) located in the NEDD4L gene is associated with salt sensitive hypertension and suggested that carriers of NEDD4L rs4149601 G-allele have higher ENaC expression compared with carriers of A-allele.40

Genes of Sympathetic Nervous System

The sympathetic nervous system is a primary regulator of acute change in BP and increased sympathetic function has reported in salt sensitive hypertension.41

Weber et al. found that salt-sensitive men have increased noradrenergic receptor sensitivity and circulating cortisol levels.42

The genes encoding for β2-adrenergic receptor (ADRβ2) is located on chromosome 10qr and encoded 477 amino acids. Eisenach et al. found that an amino terminal variant in the β2-adreno receptor that encodes glycin instead of argennin (Arg16gly) has been associated with salt sensitive hypertension.43 Pojoga et al. found a Similar association between this polymorphism and BP in normotensive people.44 Svetkey et al. reported that dietary Na+ restriction blunted the increased NO-mediated β2-ADR responsiveness in Gly16 homozygotes observed in a previous study after normal dietary Na+ intake and demonstrated that β2-ADR downregulation might serve to explain the decreased β2-adreno receptor expression on the fibroblasts of salt sensitive individuals compare with salt resistant and normotensive people.45

Another study has been found that the β2-ADR C79G and β2-ADR A46G SNPs were associated with salt sensitive hypertension. Pojoga et al. have reported that greater risk of salt sensitive hypertension is associated with an allele of A46G and the C allele of C79G.44 They compared the dietary change (from low- to high-sodium balance) in mean arterial pressure (MAP) among the 171 hypertensive subjects. Although baseline (low-sodium) BP was similar among genotype groups, MAP differed significantly by genotype, the 46AA and 79CC homozygotes demonstrated the greatest MAP.

β-3 Subunit of G-Protein

The β-adrenoreceptor-G-protein system is essential for function of adenylyl cyclase.46 Bagos et al. have been reported that polymorphism C825T in exon 19 is associated with salt sensitive hypertension.47 The T allele of this polymorphism is associated with higher risk of salt sensitive hypertension. Siffert et al. found that carriers of TT homozygotes and TC heterozygotes have a higher risk of hypertension compare with CC homozygotes.48

Alpha-Adducin

Adducins are a cytoskeletal protein that may regulate the membrane organization of spectrin-actin.49 Manunta et al. found that a mutation (Gly460Trp) in human’s α-adducin was reported to be associated with salt sensitive hypertension.40 Manunta et al. found the association between Gly460Trp allele and hypertension in some population.50 Wang et al. in a recent meta-analysis involving 454 salt sensitive and 366 non-salt sensitive participants concluded that the association between ADD1 Gly460Trp and salt sensitivity is statistically significant in Asian, but not Caucasian populations; the difference may be related to the greater frequency of ADD1 Gly460Trp in Asians than in Caucasians.51 Wang et al. found that the interaction among ADD1 Gly460Trp, ACE DD, and CYP11B2 −344CC may contribute to the BP response to dietary salt.52

Endothelial Nitric Oxide Synthase

Nitric oxide (NO) is a vasodilator that produced from l-arginine by NO synthase. Harsha et al. reported the association between Glu298Asp variant with hypertension.53 Miyaki et al. found that two polymorphisms of NO synthase, T786C and G894T have been associated with essential hypertension.54 Dengel et al. found an association between T786C polymorphism and salt sensitive hypertension.55

Kallikrein-Kinin System

This system has important roles in the kidney to increase renal blood flow.56 Chao et al. found that the Q121E SNP of kallikrein gene was reported to be associated with hypertension.57 Cervenka et al. found that deletion of the bradykininB2 receptor gene in mice produces salt-sensitive hypertension.58

Conclusion

There is evidence that genetic predisposition modulates the BP response to diet. On the other hand, diet and nutrition can mitigate or enhance the effects of genetic predisposition. Increasing our knowledge of this relationship can lead to physiologically individualized treatment and increased understanding of Pathophysiology. Major focuses in clinical research are to develop personalized treatment strategies that are preemptive and to allow persons to be proactive. While we await new studies that allow us to tailor such interventions and treatments, we must not lose sight of the wealth of information already accumulated on the effects of lifestyle modifications on BP. Reduced sodium intake, the DASH diet, weight loss, and exercise have substantial effects in almost all subgroups of the population and should continue to be widely and broadly promoted.

Footnotes

Conflicts of Interest

Authors have no conflict of interests.

REFERENCES

  • 1.Hickler RB. "Hypertensive emergency": a useful diagnostic category. Am J Public Health. 1988;78(6):623–4. doi: 10.2105/ajph.78.6.623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension. 1995;26(1):60–9. doi: 10.1161/01.hyp.26.1.60. [DOI] [PubMed] [Google Scholar]
  • 3.Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008;51(6):1403–19. doi: 10.1161/HYPERTENSIONAHA.108.189141. [DOI] [PubMed] [Google Scholar]
  • 4.Doaee S, Gholamalizadeh M. Polymorphism of A I, A IV and E apolipoprotein genes and effect of fat intake on HDL levels. Genetics in the 3rd Millennium. 2011;9(1):2323–8. [Google Scholar]
  • 5.Knight BS, Sunn N, Pennell CE, Adamson SL, Lye SJ. Developmental regulation of cardiovascular function is dependent on both genotype and environment. Am J Physiol Heart Circ Physiol. 2009;297(6):H2234–H2241. doi: 10.1152/ajpheart.01338.2008. [DOI] [PubMed] [Google Scholar]
  • 6.Hedayati SS, Elsayed EF, Reilly RF. Non-pharmacological aspects of blood pressure management: what are the data? Kidney Int. 2011;79(10):1061–70. doi: 10.1038/ki.2011.46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Safavi SM, Doaei S, Gholamalizadeh M. Unsaid of nutrition and genetics. The World of Nutrition Journal. 2007;6(60):22–3. [Google Scholar]
  • 8.Doaei S, Gholamalizadeh M. The association between dietary fat with gene polymorphisms.. Proceedings of the 11th Iranian Nutrition Congress; 2010 Nov 1-4;; 2010 Nov 1-4; Shiraz, Iran. 2010. [Google Scholar]
  • 9.Doaei S, Gholamalizadeh M, Akbari M, Safavi SM. Nutritional genomics: a window to the future. 1st. Qom, Iran: Andishe Mandegar Publication; 2011. pp. p. 5-9.–9. [Google Scholar]
  • 10.He FJ, MacGregor GA. How far should salt intake be reduced? Hypertension. 2003;42(6):1093–9. doi: 10.1161/01.HYP.0000102864.05174.E8. [DOI] [PubMed] [Google Scholar]
  • 11.Cohen HW, Alderman MH. Sodium, blood pressure, and cardiovascular disease. Curr Opin Cardiol. 2007;22(4):306–10. doi: 10.1097/HCO.0b013e3281527901. [DOI] [PubMed] [Google Scholar]
  • 12.Cowley AW. Genetic and nongenetic determinants of salt sensitivity and blood pressure. Am J Clin Nutr. 1997;65(2 Suppl):587S–93S. doi: 10.1093/ajcn/65.2.587S. [DOI] [PubMed] [Google Scholar]
  • 13.Doaei S, Gholamalizadeh M. The association of genetic variations with sensitivity of blood pressure to dietary salt.. Proceedings of the 1st International Congress on Prevention, Diagnosis & Management of Hypertension in Iran; 2011, Sep 27-29; Isfahan, Iran. 2011. [Google Scholar]
  • 14.Poch E, Gonzalez D, Giner V, Bragulat E, Coca A, de La. Molecular basis of salt sensitivity in human hypertension. Evaluation of renin-angiotensin-aldosterone system gene polymorphisms. Hypertension. 2001;38(5):1204–9. doi: 10.1161/hy1101.099479. [DOI] [PubMed] [Google Scholar]
  • 15.Meneton P, Jeunemaitre X, de Wardener HE, MacGregor GA. Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev. 2005;85(2):679–715. doi: 10.1152/physrev.00056.2003. [DOI] [PubMed] [Google Scholar]
  • 16.Caprioli J, Mele C, Mossali C, Gallizioli L, Giacchetti G, Noris M, et al. Polymorphisms of EDNRB, ATG, and ACE genes in salt-sensitive hypertension. Can J Physiol Pharmacol. 2008;86(8):505–10. doi: 10.1139/Y08-045. [DOI] [PubMed] [Google Scholar]
  • 17.Zhang L, Miyaki K, Araki J, Song Y, Kimura T, Omae K, et al. Interaction of angiotensin I-converting enzyme insertion-deletion polymorphism and daily salt intake influences hypertension in Japanese men. Hypertens Res. 2006;29(10):751–8. doi: 10.1291/hypres.29.751. [DOI] [PubMed] [Google Scholar]
  • 18.Strazzullo P, Galletti F. Genetics of salt-sensitive hypertension. Curr Hypertens Rep. 2007;9(1):25–32. doi: 10.1007/s11906-007-0006-6. [DOI] [PubMed] [Google Scholar]
  • 19.Norat T, Bowman R, Luben R, Welch A, Khaw KT, Wareham N, et al. Blood pressure and interactions between the angiotensin polymorphism AGT M235T and sodium intake: a cross-sectional population study. Am J Clin Nutr. 2008;88(2):392–7. doi: 10.1093/ajcn/88.2.392. [DOI] [PubMed] [Google Scholar]
  • 20.Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992;71(1):169–80. doi: 10.1016/0092-8674(92)90275-h. [DOI] [PubMed] [Google Scholar]
  • 21.Schorr U, Blaschke K, Beige J, Distler A, Sharma AM. Angiotensinogen M235T variant and salt sensitivity in young normotensive Caucasians. J Hypertens. 1999;17(4):475–9. doi: 10.1097/00004872-199917040-00004. [DOI] [PubMed] [Google Scholar]
  • 22.Hunt SC, Cook NR, Oberman A, Cutler JA, Hennekens CH, Allender PS, et al. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention phase II. Hypertension. 1998;32(3):393–401. doi: 10.1161/01.hyp.32.3.393. [DOI] [PubMed] [Google Scholar]
  • 23.Beeks E, Kessels AG, Kroon AA, van der Klauw MM, de Leeuw PW. Genetic predisposition to salt-sensitivity: a systematic review. J Hypertens. 2004;22(7):1243–9. doi: 10.1097/01.hjh.0000125443.28861.0d. [DOI] [PubMed] [Google Scholar]
  • 24.Svetkey LP, Harris EL, Martin E, Vollmer WM, Meltesen GT, Ricchiuti V, et al. Modulation of the BP response to diet by genes in the renin-angiotensin system and the adrenergic nervous system. Am J Hypertens. 2011;24(2):209–17. doi: 10.1038/ajh.2010.223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev. 2007;59(3):251–87. doi: 10.1124/pr.59.3.3. [DOI] [PubMed] [Google Scholar]
  • 26.Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, Kumar AP, et al. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci U S A. 2006;103(47):17985–90. doi: 10.1073/pnas.0605545103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Gu D, Kelly TN, Hixson JE, Chen J, Liu D, Chen JC, et al. Genetic variants in the renin-angiotensin-aldosterone system and salt sensitivity of blood pressure. J Hypertens. 2010;28(6):1210–20. [PMC free article] [PubMed] [Google Scholar]
  • 28.Pinto V, Pinho MJ, Hopfer U, Jose PA, Soares-da-Silva P. Oxidative stress and the genomic regulation of aldosterone-stimulated NHE1 activity in SHR renal proximal tubular cells. Mol Cell Biochem. 2008;310(1-2):191–201. doi: 10.1007/s11010-007-9680-6. [DOI] [PubMed] [Google Scholar]
  • 29.White PC, Rainey WE. Editorial: polymorphisms in CYP11B genes and 11-hydroxylase activity. J Clin Endocrinol Metab. 2005;90(2):1252–5. doi: 10.1210/jc.2004-2452. [DOI] [PubMed] [Google Scholar]
  • 30.Brand E, Chatelain N, Mulatero P, Fery I, Curnow K, Jeunemaitre X, et al. Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension. 1998;32(2):198–204. doi: 10.1161/01.hyp.32.2.198. [DOI] [PubMed] [Google Scholar]
  • 31.Matsubara M, Sato T, Nishimura T, Suzuki M, Kikuya M, Metoki H, et al. CYP11B2 polymorphisms and home blood pressure in a population-based cohort in Japanese: the Ohasama study. Hypertens Res. 2004;27(1):1–6. doi: 10.1291/hypres.27.1. [DOI] [PubMed] [Google Scholar]
  • 32.Tang W, Wu H, Zhou X, Cheng B, Dong Y, He L, et al. Association of the C-344T polymorphism of CYP11B2 gene with essential hypertension in Hani and Yi minorities of China. Clin Chim Acta. 2006;364(1-2):222–5. doi: 10.1016/j.cccn.2005.07.006. [DOI] [PubMed] [Google Scholar]
  • 33.White PC, Mune T, Agarwal AK. 11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr Rev. 1997;18(1):135–56. doi: 10.1210/edrv.18.1.0288. [DOI] [PubMed] [Google Scholar]
  • 34.Smolenicka Z, Bach E, Schaer A, Liechti-Gallati S, Frey BM, Frey FJ, et al. A new polymorphic restriction site in the human 11 beta-hydroxysteroid dehydrogenase type 2 gene. J Clin Endocrinol Metab. 1998;83(5):1814–7. doi: 10.1210/jcem.83.5.4933. [DOI] [PubMed] [Google Scholar]
  • 35.Alikhani-Koupaei R, Fouladkou F, Fustier P, Cenni B, Sharma AM, Deter HC, et al. Identification of polymorphisms in the human 11beta-hydroxysteroid dehydrogenase type 2 gene promoter: functional characterization and relevance for salt sensitivity. FASEB J. 2007;21(13):3618–28. doi: 10.1096/fj.07-8140com. [DOI] [PubMed] [Google Scholar]
  • 36.Thompson EE, Kuttab-Boulos H, Witonsky D, Yang L, Roe BA, Di RA. CYP3A variation and the evolution of salt-sensitivity variants. Am J Hum Genet. 2004;75(6):1059–69. doi: 10.1086/426406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Zhang L, Miyaki K, Wang W, Muramatsu M. CYP3A5 polymorphism and sensitivity of blood pressure to dietary salt in Japanese men. J Hum Hypertens. 2010;24(5):345–50. doi: 10.1038/jhh.2009.74. [DOI] [PubMed] [Google Scholar]
  • 38.Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell. 2001;104(4):545–56. doi: 10.1016/s0092-8674(01)00241-0. [DOI] [PubMed] [Google Scholar]
  • 39.Dahlberg J, Nilsson LO, von Wowern F, Melander O. Polymorphism in NEDD4L is associated with increased salt sensitivity, reduced levels of P-renin and increased levels of Nt-proANP. PLoS One. 2007;2(5):e432. doi: 10.1371/journal.pone.0000432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Manunta P, Lavery G, Lanzani C, Braund PS, Simonini M, Bodycote C, et al. Physiological interaction between alpha-adducin and WNK1-NEDD4L pathways on sodium-related blood pressure regulation. Hypertension. 2008;52(2):366–72. doi: 10.1161/HYPERTENSIONAHA.108.113977. [DOI] [PubMed] [Google Scholar]
  • 41.Yatabe MS, Yatabe J, Yoneda M, Watanabe T, Otsuki M, Felder RA, et al. Salt sensitivity is associated with insulin resistance, sympathetic over activity, and decreased suppression of circulating renin activity in lean patients with essential hypertension. Am J Clin Nutr. 2010;92(1):77–82. doi: 10.3945/ajcn.2009.29028. [DOI] [PubMed] [Google Scholar]
  • 42.Weber CS, Thayer JF, Rudat M, Sharma AM, Perschel FH, Buchholz K, et al. Salt-sensitive men show reduced heart rate variability, lower norepinephrine and enhanced cortisol during mental stress. J Hum Hypertens. 2008;22(6):423–31. doi: 10.1038/jhh.2008.11. [DOI] [PubMed] [Google Scholar]
  • 43.Eisenach JH, Schroeder DR, Pike TL, Johnson CP, Schrage WG, Snyder EM, et al. Dietary sodium restriction and beta2-adrenergic receptor polymorphism modulate cardiovascular function in humans. J Physiol. 2006;574(Pt 3):955–65. doi: 10.1113/jphysiol.2006.112102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Pojoga L, Kolatkar NS, Williams JS, Perlstein TS, Jeunemaitre X, Brown NJ, et al. Beta-2 adrenergic receptor diplotype defines a subset of salt-sensitive hypertension. Hypertension. 2006;48(5):892–900. doi: 10.1161/01.HYP.0000244688.45472.95. [DOI] [PubMed] [Google Scholar]
  • 45.Svetkey LP, Timmons PZ, Emovon O, Anderson NB, Preis L, Chen YT. Association of hypertension with beta2- and alpha2c10-adrenergic receptor genotype. Hypertension. 1996;27(6):1210–5. doi: 10.1161/01.hyp.27.6.1210. [DOI] [PubMed] [Google Scholar]
  • 46.Martin DN, Andreu EP, Ramirez LR, Garcia-Junco PS, Vallejo M, Santos RA, et al. G-protein beta-3 subunit gene C825 T polymorphism: influence on plasma sodium and potassium concentrations in essential hypertensive patients. Life Sci. 2005;77(23):2879–86. doi: 10.1016/j.lfs.2005.02.030. [DOI] [PubMed] [Google Scholar]
  • 47.Bagos PG, Elefsinioti AL, Nikolopoulos GK, Hamodrakas SJ. The GNB3 C825T polymorphism and essential hypertension: a meta-analysis of 34 studies including 14,094 cases and 17,760 controls. J Hypertens. 2007;25(3):487–500. doi: 10.1097/HJH.0b013e328011db24. [DOI] [PubMed] [Google Scholar]
  • 48.Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R, et al. Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet. 1998;18(1):45–8. doi: 10.1038/ng0198-45. [DOI] [PubMed] [Google Scholar]
  • 49.Nishi A, Eklof AC, Bertorello AM, Aperia A. Dopamine regulation of renal Na+, K(+)- ATPase activity is lacking in Dahl salt-sensitive rats. Hypertension. 1993;21(6 Pt 1):767–71. doi: 10.1161/01.hyp.21.6.767. [DOI] [PubMed] [Google Scholar]
  • 50.Manunta P, Cusi D, Barlassina C, Righetti M, Lanzani C, D'Amico M, et al. Alpha-adducin polymorphisms and renal sodium handling in essential hypertensive patients. Kidney Int. 1998;53(6):1471–8. doi: 10.1046/j.1523-1755.1998.00931.x. [DOI] [PubMed] [Google Scholar]
  • 51.Wang R, Zhong B, Liu Y, Wang C. Association between alpha-adducin gene polymorphism (Gly460Trp) and genetic predisposition to salt sensitivity: a meta-analysis. J Appl Genet. 2010;51(1):87–94. doi: 10.1007/BF03195715. [DOI] [PubMed] [Google Scholar]
  • 52.Wang JG, Liu L, Zagato L, Xie J, Fagard R, Jin K, et al. Blood pressure in relation to three candidate genes in a Chinese population. J Hypertens. 2004;22(5):937–44. doi: 10.1097/00004872-200405000-00015. [DOI] [PubMed] [Google Scholar]
  • 53.Harsha DW, Sacks FM, Obarzanek E, Svetkey LP, Lin PH, Bray GA, et al. Effect of dietary sodium intake on blood lipids: results from the DASH-sodium trial. Hypertension. 2004;43(2):393–8. doi: 10.1161/01.HYP.0000113046.83819.a2. [DOI] [PubMed] [Google Scholar]
  • 54.Miyaki K, Tohyama S, Murata M, Kikuchi H, Takei I, Watanabe K, et al. Salt intake affects the relation between hypertension and the T-786C polymorphism in the endothelial nitric oxide synthase gene. Am J Hypertens. 2005;18(12 Pt 1):1556–62. doi: 10.1016/j.amjhyper.2005.06.012. [DOI] [PubMed] [Google Scholar]
  • 55.Dengel DR, Brown MD, Ferrell RE, Reynolds TH, Supiano MA. A preliminary study on T-786C endothelial nitric oxide synthase gene and renal hemodynamic and blood pressure responses to dietary sodium. Physiol Res. 2007;56(4):393–401. doi: 10.33549/physiolres.931002. [DOI] [PubMed] [Google Scholar]
  • 56.Bellini C, Ferri C, Piccoli A, Carlomagno A, Di FL, Bonavita MS, et al. The influence of salt sensitivity on the blood pressure response to exogenous kallikrein in essential hypertensive patients. Nephron. 1993;65(1):28–35. doi: 10.1159/000187436. [DOI] [PubMed] [Google Scholar]
  • 57.Chao J, Zhang JJ, Lin KF, Chao L. Human kallikrein gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in Dahl salt-sensitive rats. Hum Gene Ther. 1998;9(1):21–31. doi: 10.1089/hum.1998.9.1-21. [DOI] [PubMed] [Google Scholar]
  • 58.Cervenka L, Harrison-Bernard LM, Dipp S, Primrose G, Imig JD, El-Dahr SS. Early onset salt-sensitive hypertension in bradykininB (2) receptor null mice. Hypertension. 1999;34(2):176–80. doi: 10.1161/01.hyp.34.2.176. [DOI] [PubMed] [Google Scholar]

Articles from ARYA Atherosclerosis are provided here courtesy of Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences

RESOURCES